June 2022
224 articles-
Jun 30 · 02:59Biotechnology Daily
Apple Watch's 'AFib History' feature ripens with new FDA clearance
-
Jun 30 · 02:58Biotechnology Daily
Report finds thousands of uncounted rare diseases in challenge to current estimates
-
Jun 30 · 02:48Biotechnology Daily
Tough markets take a double hit on Vincerx's workforce, clinical program
-
Jun 30 · 02:44Biotechnology Daily
Lipid may open door to new liver drugs that sidestep serious side effects
-
Jun 30 · 01:54Bio Business News
Racing Sanofi, ImmunOs bags $74M for myeloid checkpoint trials in cancer patients
-
Jun 30 · 01:39Bio Business News
Code Bio launches with $75M to reinvent genetic medicine for rare and not-so-rare diseases
-
Jun 30 · 01:36Bio Business News
Seres Therapeutics, armed with new safety data, eyes first FDA approval for a microbiome drug
-
Jun 30 · 01:33Bio Business News
Annexon is back with final Huntington's data confirming hypothesis—and no new safety issues to declare
-
-
Jun 29 · 12:15Biotechnology Daily
Plaque to basics: New research hints Alzheimer's treatments may be looking in the wrong place
-
Jun 29 · 12:12Biotechnology Daily
ASCO: ‘Any way you slice’ it, Arcellx's CAR-T is matching J&J-Legend’s Carvykti, analyst says
-
Jun 29 · 12:11Biotechnology Daily
Illumina sequencing devices vulnerable to critical hacking risks, FDA warns
-
Jun 29 · 12:09Biotechnology Daily
New mechanism behind biotech's estrogen-targeting breast cancer drug opens the door for other hard-to-treat cancers
-
Jun 29 · 12:07Bio Business News
ASCO: Adicet's gamma delta CAR-T therapy readout paves way for pioneering phase 2 trial
-
Jun 29 · 12:04Bio Business News
Philips updates latest ventilator recall following report of patient death, 4 injuries
-
Jun 29 · 12:00Bio Business News
ADA: Dexcom CEO Kevin Sayer on putting M&A on the back burner: 'We've been the organic growth story of the decade'
-
Jun 29 · 11:56Bio Business News
BD to enter pharmacy automation market with $1.5B Parata purchase
-
Jun 29 · 10:35Market Watch
Oil trades higher as supply worries provide lift
-
Jun 28 · 00:05Biotechnology Daily
HER2 diagnostics need a revolution as AstraZeneca, Daiichi's Enhertu looks to redefine breast cancer
-
Jun 28 · 00:01Biotechnology Daily
Merus' gene-targeting cancer drug shrinks tumors. Will execs go it alone or partner?
-
Jun 27 · 23:57Biotechnology Daily
Biogen bets more than $700M on Alectos' preclinical oral Parkinson's drug to shore up pipeline
-
Jun 27 · 23:55Biotechnology Daily
It's all tied up? Mirati's KRAS data are 'identical' to Amgen's, researcher says
-
Jun 27 · 23:52Bio Business News
Praxis acts fast as depression drug flunks late-phase test, stopping trials and reducing headcount
-
Jun 27 · 23:49Bio Business News
Caris Life Sciences to launch cancer blood test that spans a whopping 22,000 genes